Global Drug Makers Favoring India
Friday, August 14, 2015
Source: The Economic Times
Far from drawing a gloomy picture of India, global drug makers seem to have turned gung ho on the country.
Most of them are introducing new patented medicines. While some of the biggest multinational firms like Johnson & Johnson, Novartis, Boehringer Ingelheim, Gilead and AstraZenecaBSE -0.05 % launched their most promising brands across therapy areas in India, others such as Bristol-Myers Squibb (BMS) and Amgen are setting themselves up for a bigger role in the Rs 90,000 crore ..